Literature DB >> 30607606

Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum.

Chun-Lian Tang1, Rong-Hui Zhang1, Zhi-Ming Liu1, Huang Jin2, Long He3.   

Abstract

Schistosomiasis is one of the most devastating parasitic diseases, making it imperative to develop efficient vaccines to control the causative flatworms called schistosomes. Regulatory T cells (Tregs) and the Th1 immune response have been implicated in the effectiveness of vaccines to control schistosomiasis, but the mechanisms underlying their effects are unclear. In this study, we evaluated the role of Tregs on the efficacy of the 14 kDa FABP (fatty acid-binding protein) vaccine against Schistosoma japonicum. BALB/c female mice were randomly divided into five groups: an uninfected group, infected control group, anti-CD25 monoclonal antibody (anti-CD25 mAb) group, FABP group, and combined anti-CD25 mAb and FABP group. Compared with FABP alone, a combined treatment with FABP and anti-CD25 mAb increased the rate of S. japonicum inhibition in mice from 30.3 to 56.08% and decreased the number of eggs per gram of liver. Compared with that of the infected control group, the percentage of Tregs in the spleen decreased significantly after single or combined treatment with FABP and anti-CD25 mAb, while it increased gradually in the anti-CD25 mAb group. Further, the secretion of Th1 cytokines, IFN-γ, and IL-2 increased in splenocytes in the anti-CD25 mAb group. Our results indicate that anti-CD25 mAb partially blocks Tregs and concomitantly enhances the Th1 type immune response, thereby enhancing the protective effect of the FABP vaccine.

Entities:  

Keywords:  Anti-CD25 mAb; Cytokines; Fatty acid-binding protein; Regulatory T cells; Schistosoma japonicum

Mesh:

Substances:

Year:  2019        PMID: 30607606     DOI: 10.1007/s00436-018-6186-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  36 in total

1.  Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.

Authors:  M Wigren; D Kolbus; P Dunér; I Ljungcrantz; I Söderberg; H Björkbacka; G N Fredrikson; J Nilsson
Journal:  J Intern Med       Date:  2010-11-29       Impact factor: 8.989

2.  Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Chun-Lian Tang; Jin Yang; Liang-Yu Cheng; Lan-Fang Cheng; Zhi-Ming Liu
Journal:  Parasitol Res       Date:  2017-08-21       Impact factor: 2.289

Review 3.  Regulatory T cells (Tregs): A major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines.

Authors:  Audrey Hubert; Nabila Seddiki
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

4.  Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection.

Authors:  Pin-Hung Lin; Weng-In Wong; Yi-Lan Wang; Meng-Ping Hsieh; Chia-Wen Lu; Chieh-Yu Liang; Sung-Hsiang Jui; Fang-Yi Wu; Pei-Jer Chen; Hung-Chih Yang
Journal:  Mucosal Immunol       Date:  2018-02-21       Impact factor: 7.313

5.  The 14-3-3 protein as a vaccine candidate against schistosomiasis.

Authors:  D Schechtman; R Tarrab-Hazdai; R Arnon
Journal:  Parasite Immunol       Date:  2001-04       Impact factor: 2.280

6.  Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults.

Authors:  Marilia Santini-Oliveira; Rhea N Coler; Juçara Parra; Valdilea Veloso; Lakshmi Jayashankar; Patricia M Pinto; Marcia A Ciol; Robert Bergquist; Steven G Reed; Miriam Tendler
Journal:  Vaccine       Date:  2015-11-10       Impact factor: 3.641

7.  IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.

Authors:  Cristina T Fonseca; Cristiana F A Brito; José B Alves; Sergio C Oliveira
Journal:  Vaccine       Date:  2004-01-02       Impact factor: 3.641

8.  A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues.

Authors:  R K Ockner; J A Manning; R B Poppenhausen; W K Ho
Journal:  Science       Date:  1972-07-07       Impact factor: 47.728

9.  Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice.

Authors:  Ibrahim Rabia Aly; M Diab; A M El-Amir; M Hendawy; S Kadry
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

10.  Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.

Authors:  Lijun Mo; Xinji Zhang; Xiaojun Shi; Lili Wei; Dianpeng Zheng; Hongwei Li; Jimin Gao; Jinlong Li; Zhiming Hu
Journal:  Cancer Sci       Date:  2018-06-21       Impact factor: 6.716

View more
  1 in total

1.  Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum.

Authors:  Chun-Lian Tang; Qun Pan; Ya-Ping Xie; Ying Xiong; Rong-Hui Zhang; Jin Huang
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.